Ratings by Bernstein SocGen Group (William Pickering)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/21/2026 | Roivant Sciences | ROIV | Maintain | Outperform (N/A) |
|
Details | ||
| 5/21/2026 | Immunovant | IMVT | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/18/2026 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2026 | Intellia Therapeutics | NTLA | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/13/2026 | Dyne Therapeutics | DYN | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/13/2026 | CRISPR Therapeutics | CRSP | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/13/2026 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2026 | Arrowhead Pharma | ARWR | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/5/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2026 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2026 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/30/2026 | Biogen | BIIB | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/30/2026 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2026 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/14/2026 | Allogene | ALLO | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/8/2026 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2026 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2026 | Immunovant | IMVT | New Coverage | Market Perform (N/A) |
23.60 (39.57) |
67.67% | Details | |
| 3/19/2026 | Roivant Sciences | ROIV | New Coverage | Outperform (N/A) |
27.80 (41.48) |
49.21% | Details | |
| 3/10/2026 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2026 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/26/2026 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2026 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/3/2026 | Biogen | BIIB | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/2/2026 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/27/2026 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Intellia Therapeutics | NTLA | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/12/2026 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/12/2026 | CRISPR Therapeutics | CRSP | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/12/2026 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Biogen | BIIB | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/12/2026 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Vertex | VRTX | Upgrade | Outperform (Market Perform) |
463.86 (528.90) |
14.02% | Details | |
| 1/7/2026 | Arrowhead Pharma | ARWR | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/6/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/2/2026 | Arrowhead Pharma | ARWR | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/11/2025 | BridgeBio Pharma | BBIO | New Coverage | Outperform (N/A) |
71.67 (74.76) |
4.31% | Details | |
| 12/9/2025 | Dyne Therapeutics | DYN | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/2/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/25/2025 | Dyne Therapeutics | DYN | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/20/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2025 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/6/2025 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Market Perform (Outperform) |
13.95 (14.72) |
5.52% | Details | |
| 11/4/2025 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/3/2025 | Biogen | BIIB | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/3/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2025 | Intellia Therapeutics | NTLA | Downgrade | Market Perform (Outperform) |
25.60 (12.74) |
-50.23% | Details | |
| 10/27/2025 | Avidity Biosciences | RNA | Downgrade | Market Perform (Outperform) |
48.55 (11.35) |
-76.62% | Details | |
| 9/3/2025 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/27/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2025 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/4/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2025 | Sarepta Therapeutics | SRPT | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/30/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2025 | Sarepta Therapeutics | SRPT | New Coverage | Market Perform (N/A) |
11.93 (20.94) |
75.52% | Details | |
| 7/8/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2025 | Dyne Therapeutics | DYN | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/24/2025 | Dyne Therapeutics | DYN | New Coverage | Market Perform (N/A) |
10.32 (20.31) |
96.8% | Details | |
| 6/24/2025 | Avidity Biosciences | RNA | New Coverage | Outperform (N/A) |
29.31 (48.55) |
65.64% | Details | |
| 6/5/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/5/2025 | CRISPR Therapeutics | CRSP | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/5/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/5/2025 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/5/2025 | Arrowhead Pharma | ARWR | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/5/2025 | Allogene | ALLO | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/2/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/19/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2025 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/6/2025 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/3/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/27/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2025 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2025 | Beam Therapeutics Inc | BEAM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/4/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2025 | Ionis Pharmaceuticals | IONS | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/20/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2025 | Biogen | BIIB | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/14/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2025 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/11/2025 | Biogen | BIIB | New Coverage | Market Perform (N/A) |
141.35 (212.50) |
50.34% | Details | |
| 2/4/2025 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/31/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/15/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | Regeneron Pharma | REGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | Beam Therapeutics Inc | BEAM | Upgrade | Outperform (Market Perform) |
26.36 (26.83) |
1.78% | Details | |
| 12/20/2024 | Vertex | VRTX | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/17/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/29/2024 | Arrowhead Pharma | ARWR | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/17/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2024 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Outperform (N/A) |
38.17 (13.95) |
-63.45% | Details | |
| 8/28/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/20/2024 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Outperform (Market Perform) |
89.53 (64.63) |
-27.81% | Details | |
| 6/14/2024 | Ionis Pharmaceuticals | IONS | Upgrade | Market Perform (Underperform) |
41.50 (56.71) |
36.65% | Details | |
| 3/12/2024 | Regeneron Pharma | REGN | New Coverage | Outperform (N/A) |
968.83 (810.31) |
-16.36% | Details | |
| 2/2/2024 | Vertex | VRTX | Downgrade | Market Perform (Outperform) |
433.38 (463.86) |
7.03% | Details | |
| 1/2/2024 | Ionis Pharmaceuticals | IONS | Maintain | Underperform (N/A) |
|
Details | ||
| 1/2/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/2/2024 | Arrowhead Pharma | ARWR | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/2/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2023 | BioMarin Pharmaceutical Inc. | BMRN | Upgrade | Market Perform (Underperform) |
82.59 (89.53) |
8.4% | Details | |
| 8/15/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2023 | CRISPR Therapeutics | CRSP | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/15/2023 | Beam Therapeutics Inc | BEAM | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/2/2023 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2023 | Vertex | VRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/21/2023 | Vertex | VRTX | New Coverage | Outperform (N/A) |
295.77 (528.90) |
78.82% | Details | |
| 3/21/2023 | Intellia Therapeutics | NTLA | New Coverage | Outperform (N/A) |
39.84 (25.60) |
-35.74% | Details | |
| 3/21/2023 | Ionis Pharmaceuticals | IONS | New Coverage | Underperform (N/A) |
35.18 (56.71) |
61.2% | Details | |
| 3/21/2023 | CRISPR Therapeutics | CRSP | New Coverage | Market Perform (N/A) |
45.74 (54.78) |
19.76% | Details | |
| 3/21/2023 | BioMarin Pharmaceutical Inc. | BMRN | New Coverage | Underperform (N/A) |
91.67 (64.63) |
-29.5% | Details | |
| 3/21/2023 | Beam Therapeutics Inc | BEAM | New Coverage | Market Perform (N/A) |
33.22 (26.83) |
-19.24% | Details | |
| 3/21/2023 | Arrowhead Pharma | ARWR | New Coverage | Market Perform (N/A) |
24.30 (85.11) |
250.25% | Details | |
| 3/21/2023 | Alnylam Pharmaceuticals | ALNY | New Coverage | Outperform (N/A) |
185.45 (260.10) |
40.25% | Details | |
| 3/21/2023 | Allogene | ALLO | New Coverage | Market Perform (N/A) |
5.49 (1.85) |
-66.3% | Details |
